Patents by Inventor Frank Fazio

Frank Fazio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9138521
    Abstract: An ultrafiltration device and method for the removal of excess fluid in hypervolemic patients and/or removal of toxins in the blood including for patients suffering from either renal or cardiovascular disease is disclosed. An embodiment of the device includes a housing containing multiple large bore hollow fiber membranes which are connected to the patient's vascular system via a connecting element comprising bifurcated fluid pathway elements to physiologically channel the blood flow either to or from each hollow fiber membrane of the device, a channel to direct the fluid removed by the device to a suitable collection container or the patient's bladder, and controls that control excessive removal of the water from the patient. Devices can be either worn extracorporeally or surgically implanted in order to allow for continuous fluid removal with ambulatory freedom.
    Type: Grant
    Filed: June 25, 2012
    Date of Patent: September 22, 2015
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Barry A. Solomon, Gregory S. Erman, Frank A. Fazio
  • Publication number: 20120265118
    Abstract: An ultrafiltration device and method for the removal of excess fluid in hypervolemic patients and/or removal of toxins in the blood including for patients suffering from either renal or cardiovascular disease is disclosed. An embodiment of the device includes a housing containing multiple large bore hollow fiber membranes which are connected to the patient's vascular system via a connecting element comprising bifurcated fluid pathway elements to physiologically channel the blood flow either to or from each hollow fiber membrane of the device, a channel to direct the fluid removed by the device to a suitable collection container or the patient's bladder, and controls that control excessive removal of the water from the patient. Devices can be either worn extracorporeally or surgically implanted in order to allow for continuous fluid removal with ambulatory freedom.
    Type: Application
    Filed: June 25, 2012
    Publication date: October 18, 2012
    Applicant: Fresenius Medical Care Holdings, Inc.
    Inventors: Barry A. Solomon, Gregory S. Erman, Frank A. Fazio
  • Patent number: 8241239
    Abstract: An ultrafiltration device and method for the removal of excess fluid in hypervolemic patients and/or removal of toxins in the blood including for patients suffering from either renal or cardiovascular disease is disclosed. An embodiment of the device includes a housing containing multiple large bore hollow fiber membranes which are connected to the patient's vascular system via a connecting element comprising bifurcated fluid pathway elements to physiologically channel the blood flow either to or from each hollow fiber membrane of the device, a channel to direct the fluid removed by the device to a suitable collection container or the patient's bladder, and controls that control excessive removal of the water from the patient. Devices can be either worn extracorporeally or surgically implanted in order to allow for continuous fluid removal with ambulatory freedom.
    Type: Grant
    Filed: February 23, 2009
    Date of Patent: August 14, 2012
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Barry A. Solomon, Gregory S. Erman, Frank A. Fazio
  • Publication number: 20090234266
    Abstract: An ultrafiltration device and method for the removal of excess fluid in hypervolemic patients and/or removal of toxins in the blood including for patients suffering from either renal or cardiovascular disease is disclosed. An embodiment of the device includes a housing containing multiple large bore hollow fiber membranes which are connected to the patient's vascular system via a connecting element comprising bifurcated fluid pathway elements to physiologically channel the blood flow either to or from each hollow fiber membrane of the device, a channel to direct the fluid removed by the device to a suitable collection container or the patient's bladder, and controls that control excessive removal of the water from the patient. Devices can be either worn extracorporeally or surgically implanted in order to allow for continuous fluid removal with ambulatory freedom.
    Type: Application
    Filed: February 23, 2009
    Publication date: September 17, 2009
    Applicant: Fresenius Medical Care Holdings, Inc.
    Inventors: Barry A. Solomon, Gregory S. Erman, Frank A. Fazio
  • Publication number: 20090204521
    Abstract: A system and method for web-based mortgage/loan reporting and management are provided. A electronic mortgage is created. The mortgage is reported to parties involved. A funds request can be sent to a funding party such as a financial institutions. When a funding acknowledgement has been received a final mortgage report is generated and sent to the relevant parties for confirmation of completion of the mortgage.
    Type: Application
    Filed: December 15, 2008
    Publication date: August 13, 2009
    Inventors: Francis E. De Sena, Frank Fazio, Jeff E. Nantais
  • Publication number: 20020052571
    Abstract: An implantable, or compact, extracorporeal, artificial kidney that generally comprises: at least one blood inlet conduit, at least one microfluidic filter, a support for said filter, at least one blood outlet conduit and at least one blood solute outlet conduit, and methods for using the kidney.
    Type: Application
    Filed: September 13, 2001
    Publication date: May 2, 2002
    Inventor: Frank A. Fazio